CBD

Patient Demand for Medicinal Cannabis in Australia Continues to Grow

Retrieved on: 
Thursday, December 1, 2022

In 2018, the TGA (Therapeutic Goods Administration) changed the system medical practitioners had to follow to apply for medicinal cannabis products.

Key Points: 
  • In 2018, the TGA (Therapeutic Goods Administration) changed the system medical practitioners had to follow to apply for medicinal cannabis products.
  • Levin Health says this highlights a major uplift in clinicians that want to make medicinal cannabis a regular treatment option.
  • With more than 200 different medicinal cannabis products available, patients can choose between oils, capsules, nasal sprays and oral sprays.
  • The average individual spend now sits at $278 a month for cannabis Melbourne and Australia wide, with the average price per mg of cannabinoid continuing to drop.

Monvera Glass Decoration Celebrates its 15th Anniversary with Continued Investment in Growth and Expansion

Retrieved on: 
Thursday, December 1, 2022

RICHMOND, Calif., Dec. 1, 2022 /PRNewswire-PRWeb/ -- Monvera Glass Decoration, an industry leader in screen printed bottles is celebrating its 15th anniversary with a further expansion of its printing and warehouse facility and a newly published website.

Key Points: 
  • RICHMOND, Calif., Dec. 1, 2022 /PRNewswire-PRWeb/ -- Monvera Glass Decoration, an industry leader in screen printed bottles is celebrating its 15th anniversary with a further expansion of its printing and warehouse facility and a newly published website.
  • Monvera's production and warehouse facility has grown to 82,000 square feet within the historic Ford Assembly Building on the waterfront in Richmond, California.
  • The addition of this new warehouse space marks our 4th major expansion", says Caitriona Anderson, Monvera's VP of Sales & Marketing.
  • Monvera is an industry leader in glass bottle decoration specializing in screen-printed labels.

IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease

Retrieved on: 
Thursday, December 1, 2022

Currently, there is no Food and Drug Administration (FDA) approved drug for treating agitation in dementia related to Alzheimers (Jones et al., 2021).

Key Points: 
  • Currently, there is no Food and Drug Administration (FDA) approved drug for treating agitation in dementia related to Alzheimers (Jones et al., 2021).
  • We believe that IGC-AD1 has the potential to revolutionize the treatment of Alzheimers Disease as the first and only low-dose natural THC-based formulation candidate currently undergoing FDA trials, commented Ram Mukunda, CEO of IGC.
  • Through these and further trials, we look forward to establishing IGC-AD1s efficacy in treating the symptoms related to Alzheimers Disease.
  • IGC-AD1 relies on low-doses of THC, a psychoactive cannabinoid, and another compound as active agents in trials for Alzheimers.

Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Files EZ-G Patent Application to Include Double Faceted Condom

Retrieved on: 
Thursday, December 1, 2022

ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 01, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (BYND Cannasoft or the Company) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design.

Key Points: 
  • ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 01, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (BYND Cannasoft or the Company) announced today the filing of a patent application for its EZ-G device to include an innovative double-faceted condom design.
  • According to the patent application, the condom will have a double pocket that will contain a lubricant that is released evenly when used.
  • Yftah Ben Yaackov, CEO and Director of BYND Cannasoft, said, The filing of our patent application for the EZ-G device to include a double-faceted condom design could create additional value for BYND Cannasoft.
  • Should we be successful with the examination of our patent application, the global condom market is fragmented, but growing significantly.

Global Cannabis Extraction Market Report 2022: Historic Market Revenue for 2021, Estimates for 2022, and CAGR Projections Through 2027

Retrieved on: 
Thursday, December 1, 2022

This report studies the global market for cannabis extraction equipment and services using 2021 as a base year and provides estimates for each year of the forecast period, 2022-2027, with projections for CAGR.

Key Points: 
  • This report studies the global market for cannabis extraction equipment and services using 2021 as a base year and provides estimates for each year of the forecast period, 2022-2027, with projections for CAGR.
  • The scope of this report is limited and covers global markets for cannabis extraction equipment and services only.
  • This report provides market insights into the global cannabis extraction market, focusing on the U.S., Europe, Asia and the top cannabis extraction companies in those countries.
  • It explains the foremost market drivers of the global cannabis extraction market, current trends within the industry, and the regional dynamics of the cannabis extraction market.

Nass Valley Gardens Announces It Has Contracted Its Reg A+ Capital Raise Team

Retrieved on: 
Thursday, December 1, 2022

WEST PALM BEACH, FL via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and a wholly-owned subsidiary of Nass Valley Gateway Ltd., (CSE:NVG) (OTC:NSVGF)(FSE:3NVN), announced today it has finalized and contracted its Reg A+ public offering team.

Key Points: 
  • WEST PALM BEACH, FL via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and a wholly-owned subsidiary of Nass Valley Gateway Ltd., (CSE:NVG) (OTC:NSVGF)(FSE:3NVN), announced today it has finalized and contracted its Reg A+ public offering team.
  • Nass Valley Gateway Ltd. CEO Michael Semler stated, We have assembled and contracted our team to launch our Regulation A+ offering.
  • Nass Valley Gardens is excited to be working with these leading partners and we're pleased to update our investors and stakeholders as to our Reg A+ progress.
  • ABOUT NASS VALLEY GARDENS INC.
    Nass Valley Gardens Inc. is a subsidiary of Nass Valley Gateway LTD (NVG), a publicly traded company on the CSE.

Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

Retrieved on: 
Wednesday, November 30, 2022

There is an offering document (the Offering Document) related to the Offering that can be accessed under the Companys profile at www.sedar.com and on the Companys website at https://revivethera.com .

Key Points: 
  • There is an offering document (the Offering Document) related to the Offering that can be accessed under the Companys profile at www.sedar.com and on the Companys website at https://revivethera.com .
  • As disclosed in the Offering Document, the company intends to use the net proceeds for general working capital purposes and clinical development.
  • The Offering is anticipated to close on or about December 14, 2022, or such later date as the Company may determine.
  • With its acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders.

Nass Valley Gardens Announces It Has Contracted Its Reg A+ Capital Raise Team

Retrieved on: 
Wednesday, November 30, 2022

WEST PALM BEACH, FL, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and a wholly-owned subsidiary of Nass Valley Gateway Ltd., (CSE:NVG) (OTC:NSVGF)(FSE:3NVN), announced today it has finalized and contracted its Reg A+ public offering team.                  Nass Valley Gateway Ltd. CEO Michael Semler stated, “We have assembled and contracted our team to launch our Regulation A+ offering. LifeWater Media will lead our marketing efforts and DealMaker will be our technical platform, along with Hybrid Financial as our IR team. Equiniti will handle our shareholder services. Nass Valley Gardens is excited to be working with these leading partners and we're pleased to update our investors and stakeholders as to our Reg A+ progress.”

Key Points: 
  • WEST PALM BEACH, FL, Nov. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nass Valley Gardens Inc., a Nevada registered C-Corp and a wholly-owned subsidiary of Nass Valley Gateway Ltd., (CSE:NVG) (OTC:NSVGF)(FSE:3NVN), announced today it has finalized and contracted its Reg A+ public offering team.
  • Nass Valley Gateway Ltd. CEO Michael Semler stated, We have assembled and contracted our team to launch our Regulation A+ offering.
  • Nass Valley Gardens is excited to be working with these leading partners and we're pleased toupdate our investors and stakeholders as to our Reg A+ progress.
  • ABOUT NASS VALLEY GARDENS INC.
    Nass Valley Gardens Inc. is a subsidiary of Nass Valley Gateway LTD (NVG), a publicly traded company on the CSE.

Tejon Ranch Co. Announces Settlement of Litigation Related to the Tejon Ranch Conservation and Land Use Agreement

Retrieved on: 
Wednesday, November 30, 2022

TEJON RANCH, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Tejon Ranch Co. is pleased to announce the resolution of a legal dispute involving the Tejon Ranch Conservancy and the signatories to the 2008 Tejon Ranch Conservation and Land Use Agreement (Agreement), namely, Audubon California, Endangered Habitats League, Natural Resources Defense Council, Planning and Conservation League, and the Sierra Club.

Key Points: 
  • TEJON RANCH, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Tejon Ranch Co. is pleased to announce the resolution of a legal dispute involving the Tejon Ranch Conservancy and the signatories to the 2008 Tejon Ranch Conservation and Land Use Agreement (Agreement), namely, Audubon California, Endangered Habitats League, Natural Resources Defense Council, Planning and Conservation League, and the Sierra Club.
  • The 2008 Tejon Ranch Conservation and Land Use Agreement has been widely hailed as a historic conservation achievement in preserving one of Californias great natural and working landscapes.
  • Tejon Ranch Co.s agreement to conserve 90 percent of its landholdings pursuant to the Agreement is a monumental contribution to conservation in California.
  • These funds are the final fulfilment of Tejon Ranch Co.s full funding obligations under the Agreement, totaling $11,760,000 over the past 14 years, again demonstrating Tejon Ranch Co.s commitment to fulfilling the implementation of the 2008 Tejon Ranch Conservation and Land Use Agreement.

IGC to Present at the RHK 2022 Disruptive Growth Conference

Retrieved on: 
Wednesday, November 30, 2022

POTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc (NYSE American: IGC) (IGC or the Company) today announced that Ram Mukunda, Chief Executive Officer, will be presenting at the RHK Disruptive Growth Conference in New York City on Monday, December 5 at 11:20 am ET and will be available for one-on-one meetings on Monday, December 5 and Tuesday, December 6.

Key Points: 
  • POTOMAC, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc (NYSE American: IGC) (IGC or the Company) today announced that Ram Mukunda, Chief Executive Officer, will be presenting at the RHK Disruptive Growth Conference in New York City on Monday, December 5 at 11:20 am ET and will be available for one-on-one meetings on Monday, December 5 and Tuesday, December 6.
  • India Globalization Capital Inc. develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimers disease, Parkinsons disease, chronic pain, and pet seizures.
  • IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on June 23, 2022, as if fully incorporated and restated herein.
  • In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur.